Half Year Results 

Consort Medical relieved by acquisition

Consort Medical relieved by acquisition

Consort Medical’s (CSRT) chief executive Jonathan Glenn always said that mergers would be necessary if the company hoped to compete with the big medical device manufacturers. A string of operational challenges provided the catalyst for a proposal that has rendered the London-listed company as a target rather than a buyer. These half-year results indicate that the take-out proposed by Swedish peer Recipharm in November is the best outcome for the company’s investors.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe
Subscribe to Investors Chronicle

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now